ACS will buy CredenceHealth

Affiliated Computer Services (ACS), a Xerox company, announced a definitive agreement to acquire Nashville, Tenn.-based CredenceHealth, a software developer whose products capture and analyze patient data.

By integrating CredenceHealth’s clinical surveillance tools with ACS’ suite of managed care tools under the Midas software brand, Dallas-based ACS will offer a cloud-based tool that monitors patient data, the company stated.

The new tool, named Midas+ Live, works with a hospital’s EMR system and alerts caregivers when changes in a patient’s condition happen simultaneously–such as an increase in temperature or low blood pressure, combined with various lab and radiology results. This information can then be used to inform the caregiver prior to a decline in the patient’s condition, ACS stated.

Justin Lanning, CEO, CredenceHealth, will serve as vice president of business development, ACS Midas+. 

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup